We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer.
- Authors
Madsen, Emilie A.; Thorlacius-Ussing, Jeppe; Nissen, Neel I.; Jensen, Christina; Chen, Inna M.; Johansen, Julia S.; Diab, Hadi M. H.; Jørgensen, Lars N.; Hansen, Carsten P.; Karsdal, Morten A.; Willumsen, Nicholas
- Abstract
Circulating fragments of type III collagen, measured by PRO-C3, has shown promising results as a tumor fibrosis biomarker. However, the fibrotic tumor microenvironment consists of many other collagens with diverse functions and unexplored biomarker potential. One example hereof is type XXII collagen (COL22). In this study, we investigated the biomarker potential of COL22 by measuring this in serum. An ELISA, named PRO-C22, was developed and measured in two serum cohorts consisting of patients with various solid tumors (n = 220) and healthy subjects (n = 33) (Cohort 1), and patients with pancreatic ductal adenocarcinoma (PDAC) (n = 34), and healthy subjects (n = 20) (Cohort 2). In Cohort 1, PRO-C22 was elevated in the serum from patients with solid tumors, compared to healthy subjects (p < 0.01 to p < 0.0001), and the diagnostic accuracy (AUROC) ranged from 0.87 to 0.98, p < 0.0001. In Cohort 2, the high levels of PRO-C22, in patients with PDAC, were predictive of a worse overall survival (HR = 4.52, 95% CI 1.90–10.7, p = 0.0006) and this remained significant after adjusting for PRO-C3 (HR = 4.27, 95% CI 1.24–10.4, p = 0.0013). In conclusion, PRO-C22 has diagnostic biomarker potential in various solid tumor types and prognostic biomarker potential in PDAC. Furthermore, PRO-C22 complemented PRO-C3 in predicting mortality, suggesting an additive prognostic value when quantifying different collagens.
- Subjects
CYSTIC fibrosis; PANCREATIC cancer; COLLAGEN; CANCER prognosis; PANCREATIC duct; CIRCULATING tumor DNA
- Publication
Cells (2073-4409), 2022, Vol 11, Issue 23, p3763
- ISSN
2073-4409
- Publication type
Article
- DOI
10.3390/cells11233763